Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: A model for detecting antipsychotic activity?

Psychopharmacology

Volumn 156, Issue 2-3, 2001, Pages 273-283

  Ouagazzal, Abdel Mouttalib ^a,b   Jenck, François ^a   Moreau, Jean Luc ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Antipsychotic; Mice; Prepulse inhibition; Schizophrenia; Startle habituation

Indexed keywords

BUSPIRONE; CLOZAPINE; DESIPRAMINE; DIAZEPAM; HALOPERIDOL; MORPHINE DERIVATIVE; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT; RISPERIDONE; SCOPOLAMINE;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ARTICLE; DRUG POTENTIATION; HABITUATION; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SCREENING TEST; SENSORIMOTOR FUNCTION; SENSORY STIMULATION; STARTLE REFLEX; STIMULUS RESPONSE;

ACOUSTIC STIMULATION; ANIMALS; ANTIPSYCHOTIC AGENTS; DRUG EVALUATION, PRECLINICAL; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MICE; MICE, INBRED STRAINS; PSYCHOTROPIC DRUGS; SPECIES SPECIFICITY; STARTLE REACTION; STIMULATION, CHEMICAL;

EID: 0034917568     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100763     Document Type: Article

References (40)

1. Effects of 6-hydroxydopamine lesions of locus coeruleus on startle in rats
2. Reversal of isolation rearing-induced deficits in prepulse inhibition by seroquel and olanzapine
3. Gating and habituation of the startle reflex in schizophrenic patients
4. Exploration of mice in black and white test box: Validation as model of anxiety
5. Distribution and quantification of 5-HT nerve cell bodies in the nucleus raphe dorsalis area of C57BL and BALBc mice. Relationship between anatomy and biochemistry
6. Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia - A study group report
7. Partial benzodiazepine agonists in schizophrenia: Expectations and present clinical findings
8. Potentiation of prepulse inhibition of the startle reflex in rats: Pharmacological evaluation of the procedure as model for detecting antipsychotic activity
9. Psychopharmacology of prepulse inhibition in mice
10. Alternative phenotypes for complex genetics of schizophrenia
11. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice
12. Genotypic differences between C57BL/6 and A inbred mice in anxiolytic and sedative actions of diazepam
13. Assessing prepulse inhibition of startle in wild-type and knockout mice
14. Startle habituation and sensorimotor gating in schizophrenia and related animal models
15. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia
16. Behavioural pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats
17. The neuropathology of schizophrenia: A critical review of the data and their interpretation
18. 2 dopamine receptors
19. Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: Reversal by haloperidol
20. 2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice
21. GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses
22. Maintaining schizophrenic patients on benzodiazepines
23. Ventral pallidal GABA-A receptors regulate prepulse inhibition of acoustic startle
24. Pharmacological validation of novel animal model of anticipatory anxiety in mice
25. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia
26. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine
27. Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids: Implications of genetic background for single gene and quantitative trait loci analyses
28. Flinders resistant hypocholinergic rats exhibit startle sensitization and reduced startle thresholds
29. Characterization of benzo-diazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice
30. Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition
31. A-receptor mutations
32. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: Focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression
33. Inbred of strain differences in prepulse inhibition of the mouse startle response
34. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia
35. GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats
36. Discrepant findings of clozapine effects on prepulse inhibition of startle: Is it the route or the rat
37. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as model to screen antipsychotic drugs
38. Critical review of GABA-ergic drug in the treatment of schizophrenia
39. Mouse strains differ in their sensitivity to alprazolam effect in the staircase test
40. Benzodiazepines in the treatment of schizophrenia: A review and reappraisal